Surface Oncology

Laurie Stelzer

Laurie Stelzer is chief financial officer at Halozyme Therapeutics where she is responsible for the finance, business development and information technology organizations. Prior to Halozyme, she held several roles at Shire, Inc. including senior vice president of finance supporting R&D, Technical Operations and M&A, CFO for the Regenerative Medicine Division and head of investor relations. Ms. Stelzer also held positions of increasing responsibility for 15 years at Amgen, Inc. including interim treasurer, head of emerging markets expansion, executive director of global commercial finance and head of global accounting.

Ms. Stelzer holds an undergraduate degree in accounting from Arizona State University and a master’s degree in business administration from the Anderson School at the University of California, Los Angeles.